Merck KGaA has teamed up with Promega Corporation (based in Madison, Wisconsin, USA) to co‑develop new biopharmaceutical technologies for drug screening and discovery using advanced three‑dimensional (3D) cell culture systems. The partnership brings together Merck’s know‑how in organoid technology and synthetic chemistry with Promega’s advanced assay and reporter tools. Together, t... https://www.coherentmarketinsights.com/news/merck-promega-team-up-to-boost-3d-cell-based-drug-discovery-1769